当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析

君实生物-U

(688180)

  

流通市值:308.32亿  总市值:413.04亿
流通股本:7.66亿   总股本:10.27亿

君实生物-U(688180)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.43亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益609010.81万元,未分配利润-1123673.16万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1415199.93万元,负债806189.12万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入726,287,839.62,498,420,333.971,805,880,133.521,168,383,949.66
营业总成本861,878,028.113,444,363,178.982,473,163,074.831,659,107,714.05
其他经营收益
营业利润-28,587,860.48-999,463,383.92-671,058,241.61-475,011,078.54
利润总额-37,842,584.71-1,023,274,342.07-692,393,121.41-485,211,590.12
净利润-43,425,421.84-1,009,393,410.45-674,309,869.11-465,673,412.19
每股收益
其他综合收益5,922,552.06-6,750,254.67-146,608.69-15,916,155.46
综合收益总额-37,502,869.78-1,016,143,665.12-674,456,477.8-481,589,567.65
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计5,874,389,312.734,457,703,511.074,445,064,264.394,784,755,600.84
非流动资产:
非流动资产合计8,277,609,988.837,924,623,384.297,242,977,370.966,890,832,474.91
资产总计14,151,999,301.5612,382,326,895.3611,688,041,635.3511,675,588,075.75
流动负债:
流动负债合计2,746,265,120.572,778,278,033.832,748,630,846.132,968,737,939.93
非流动负债:
非流动负债合计5,315,626,038.833,547,454,580.762,644,091,377.342,314,733,583.04
负债合计8,061,891,159.46,325,732,614.595,392,722,223.475,283,471,522.97
所有者权益(或股东权益):
归属于母公司股东权益合计5,896,037,652.786,030,434,432.076,216,157,386.496,372,334,459.9
股东权益合计6,090,108,142.166,056,594,280.776,295,319,411.886,392,116,552.78
负债和股东权益合计14,151,999,301.5612,382,326,895.3611,688,041,635.3511,675,588,075.75
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计841,165,588.932,841,283,482.042,139,612,068.291,404,458,148.66
经营活动现金流出小计783,316,353.943,360,851,214.362,483,022,336.461,733,846,482
经营活动产生的现金流量净额57,849,234.99-519,567,732.32-343,410,268.17-329,388,333.34
投资活动产生的现金流量:
投资活动现金流入小计660,942,551.932,325,262,549.21,718,649,206.71,207,614,304.91
投资活动现金流出小计1,202,307,578.743,905,973,432.422,627,438,852.341,760,468,211.27
投资活动产生的现金流量净额-541,365,026.81-1,580,710,883.22-908,789,645.64-552,853,906.36
筹资活动产生的现金流量:
筹资活动现金流入小计2,421,047,188.744,764,723,517.23,533,008,134.162,640,106,775.13
筹资活动现金流出小计628,698,526.332,535,417,774.791,990,436,816.31,255,742,433.16
筹资活动产生的现金流量净额1,792,348,662.412,229,305,742.411,542,571,317.861,384,364,341.97
汇率变动对现金及现金等价物的影响-12,144,143-21,706,525.95-7,377,820.48376,249.04
现金及现金等价物净增加额1,296,688,727.59107,320,600.92282,993,583.57502,498,351.31
期末现金及现金等价物余额3,890,688,437.332,593,999,709.742,769,672,692.392,989,177,460.13
补充资料:
现金及现金等价物的净增加额-107,320,600.92-502,498,351.31
最新报告期:2026-04-15
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
天风证券杨松,曹文清-0.460.180.592026-04-15
TOP↑